Health Catalyst, Inc. HCAT
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -7.54% | -2.83% | 1.48% | 4.64% | 5.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.54% | -2.83% | 1.48% | 4.64% | 5.55% |
| Cost of Revenue | -16.38% | -10.92% | -5.03% | 2.07% | 5.29% |
| Gross Profit | 2.83% | 6.70% | 9.06% | 7.63% | 5.84% |
| SG&A Expenses | -19.06% | -0.62% | 0.31% | -0.96% | -5.65% |
| Depreciation & Amortization | 7.37% | 16.35% | 21.89% | 15.47% | 8.58% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.67% | -7.01% | -2.66% | 0.27% | -0.56% |
| Operating Income | 61.68% | 32.55% | 25.58% | 20.26% | 25.11% |
| Income Before Tax | -164.53% | -266.01% | -156.27% | -34.52% | -15.82% |
| Income Tax Expenses | 157.62% | 110.34% | 115.02% | 745.64% | 15.84% |
| Earnings from Continuing Operations | -164.50% | -265.08% | -156.07% | -35.99% | -15.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -164.50% | -265.08% | -156.07% | -35.99% | -15.82% |
| EBIT | 61.68% | 32.55% | 25.58% | 20.26% | 25.11% |
| EBITDA | 164.95% | 115.31% | 86.22% | 53.40% | 48.62% |
| EPS Basic | -143.44% | -223.35% | -119.42% | -17.17% | -0.98% |
| Normalized Basic EPS | 47.55% | 17.89% | 9.02% | 2.43% | 8.52% |
| EPS Diluted | -143.44% | -223.35% | -119.42% | -17.17% | -0.98% |
| Normalized Diluted EPS | 47.55% | 17.89% | 9.02% | 2.43% | 8.52% |
| Average Basic Shares Outstanding | 10.32% | 13.13% | 16.14% | 14.89% | 12.46% |
| Average Diluted Shares Outstanding | 10.32% | 13.13% | 16.14% | 14.89% | 12.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |